In this regard, a study analyzing cancer progression of allograft hepatoma tumors in miR-21-null mice showed that CD4+ and CD8+ T cell responses were weaker in these mice, allowing for a better progression of the allografts, whereas introducing WT CD4+ and CD8+ T cells reversed the phenotype [68]. This evidence concerns the gene CD4 and cancer.